Confounding Factors of the Diabetes - Metformin - Cancer Relationship
An increasing wealth of knowledge in oncology and diabetes points to metformin, the most widely used oral anti-diabetic worldwide, as a potential anticancer drug. Metformin has not only been shown to reduce the risk of developing cancer, but recent studies have also highlighted the impact that this...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2014-09-01
|
| Series: | Romanian Journal of Diabetes Nutrition and Metabolic Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjdnmd-2014-0029 |